Clinical Trial on Pharmacokinetic and Tolerability of AP701

Clinical trial NCT04708795 · COMPLETED

Trial details

NCT number: NCT04708795
Sponsor: CannaXan GmbH
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Pharmacokinetic Tolerability Safety

Start date: 2020-01-11
Primary completion: 2021-03-07
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.